News and Events

Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research
13 Mar 2026
Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through A...
CasBio Announces Strategic Collaboration with DxD Hub to Advance CRISPR-Based STI Diagnostics
05 Feb 2026
CasBio Announces Strategic Collaboration with DxD Hub to Advance CRISPR-Based STI Diagnostics
CorDx and DxD Hub Establish POCT Centre to Drive Global Health Innovation in Infectious Diseases, Fertility Health and Chronic Diseases Diagnostics
23 Oct 2025
CorDx and DxD Hub Establish POCT Centre to Drive Global Health Innovation in Infectious Diseases, Fe...
DxD Hub Webinar Series: Advancing Diagnostics - Digital Pathology Adoption and Impact in APAC
25 Jun 2025
DxD Hub Webinar Series: Advancing Diagnostics - Digital Pathology Adoption and Impact in APAC
Singapore-developed H5 Avian Influenza Virus (AIV) Test Kit Commercialised and Licensed for Regional Distribution
17 Jun 2025
Singapore-developed H5 Avian Influenza Virus (AIV) Test Kit Commercialised and Licensed for Regional...
[Media Feature] Tumour Markers and Genetic Testing – Can They Truly Enable Early Detection?
16 May 2025
[Media Feature] Tumour Markers and Genetic Testing – Can They Truly Enable Early Detection?
A Stream of Hope: New Study to Validate Urine-Based Multi-Cancer Test
13 May 2025
A Stream of Hope: New Study to Validate Urine-Based Multi-Cancer Test
Shimadzu Corporation and DxD Hub Establish Joint Lab to Advance Diagnostics Innovation and Improve Healthcare Outcomes
10 Mar 2025
Shimadzu Corporation and DxD Hub Establish Joint Lab to Advance Diagnostics Innovation and Improve H...
Global Research Team Develops Advanced H5N1 Detection Kit to Tackle Avian Flu
02 Dec 2024
Global Research Team Develops Advanced H5N1 Detection Kit to Tackle Avian Flu
Vaccines and Immunity: Is Omicron the last threat?
02 Mar 2022
Vaccines and Immunity: Is Omicron the last threat?
Vaccines and Immunity: When can we achieve herd immunity?
08 Oct 2021
Vaccines and Immunity: When can we achieve herd immunity?
Genomic Surveillance for SARS-CoV-2 Variants: What is the impact and why we need it now?
27 Aug 2021
Genomic Surveillance for SARS-CoV-2 Variants: What is the impact and why we need it now?
MP BIOMEDICALS AND A*STAR CO-DEVELOP RAPID ANTIBODY POINT-OF-CARE TEST KIT FOR SARS-COV-2
24 Jul 2021
MP BIOMEDICALS AND A*STAR CO-DEVELOP RAPID ANTIBODY POINT-OF-CARE TEST KIT FOR SARS-COV-2
SINGAPORE TO ADVANCE COVID-19 RESEARCH COLLABORATION WITH ASEAN AND STRENGTHEN REGIONAL CAPABILITIES TO COMBAT PANDEMICS
17 Jun 2021
SINGAPORE TO ADVANCE COVID-19 RESEARCH COLLABORATION WITH ASEAN AND STRENGTHEN REGIONAL CAPABILITIES...
Direct PCR as an alternative platform to conventional PCR
28 May 2021
Direct PCR as an alternative platform to conventional PCR
Translating R&D Into COVID-19 Kits: DxD Hub and Local Medtech Firms Ramp Up Singapore’s Testing Capability
02 Mar 2021
Translating R&D Into COVID-19 Kits: DxD Hub and Local Medtech Firms Ramp Up Singapore’s Testing Capa...
From Lab to Market: Putting Diagnostics Innovations on the Fast Track
22 Feb 2021
From Lab to Market: Putting Diagnostics Innovations on the Fast Track
COVID-19 Vaccines, Immunity & Diagnostics
29 Jan 2021
COVID-19 Vaccines, Immunity & Diagnostics
PUBLIC-PRIVATE COLLABORATION LEADS TO FINGER-PRICK ANTIBODY TEST KIT FOR COVID-19 THAT DELIVERS RESULTS IN 15 MINUTES
24 Jul 2020
PUBLIC-PRIVATE COLLABORATION LEADS TO FINGER-PRICK ANTIBODY TEST KIT FOR COVID-19 THAT DELIVERS RESU...
A*STAR & PARTNERS ROLL OUT RESOLUTE 2.0 TEST AND AUTOMATED LAB SYSTEM RAVE THAT UPS TEST DELIVERY THROUGHPUT BY FOUR TIMES
23 Jul 2020
A*STAR & PARTNERS ROLL OUT RESOLUTE 2.0 TEST AND AUTOMATED LAB SYSTEM RAVE THAT UPS TEST DELIVERY TH...